Enbrel is a biologic drug used to treat immune disorders such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. It is a recombinant fusion protein composed of the extracellular ligand-binding portion of the human 75 kDa tumor necrosis factor receptor (TNFR) linked to the Fc portion of human IgG1. Enbrel works by blocking the action of tumor necrosis factor (TNF), a protein that plays a role in inflammation. Enbrel is a widely used drug in the immune disorder drug market. It is approved for use in adults and children over the age of four. It is administered as a subcutaneous injection and is available in both prefilled syringes and autoinjectors. The Enbrel market is highly competitive, with several companies offering similar products. These include Amgen, Pfizer, AbbVie, Janssen, and UCB. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
